[go: up one dir, main page]

MA63526A1 - Composition based on hemp seeds for therapeutic use - Google Patents

Composition based on hemp seeds for therapeutic use

Info

Publication number
MA63526A1
MA63526A1 MA63526A MA63526A MA63526A1 MA 63526 A1 MA63526 A1 MA 63526A1 MA 63526 A MA63526 A MA 63526A MA 63526 A MA63526 A MA 63526A MA 63526 A1 MA63526 A1 MA 63526A1
Authority
MA
Morocco
Prior art keywords
therapeutic use
composition based
hemp seeds
hemp
seeds
Prior art date
Application number
MA63526A
Other languages
French (fr)
Inventor
Dalila Bousta
Zouhayr Souirti
Berbouchi Bouzekri El
Othmane Boumaalif
Youssef Ouadrhiri
Farid Bennis
Original Assignee
LAPROPHAN ((Laboratoires de Produits Pharmaceutiques d'Afrique du Nord)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LAPROPHAN ((Laboratoires de Produits Pharmaceutiques d'Afrique du Nord) filed Critical LAPROPHAN ((Laboratoires de Produits Pharmaceutiques d'Afrique du Nord)
Priority to MA63526A priority Critical patent/MA63526A1/en
Publication of MA63526A1 publication Critical patent/MA63526A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pretreatment Of Seeds And Plants (AREA)

Abstract

La présente invention concerne une composition comprenant de la farine délipidée de graines de chanvre.The present invention relates to a composition comprising defatted hemp seed flour.

MA63526A 2023-12-19 2023-12-19 Composition based on hemp seeds for therapeutic use MA63526A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MA63526A MA63526A1 (en) 2023-12-19 2023-12-19 Composition based on hemp seeds for therapeutic use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA63526A MA63526A1 (en) 2023-12-19 2023-12-19 Composition based on hemp seeds for therapeutic use

Publications (1)

Publication Number Publication Date
MA63526A1 true MA63526A1 (en) 2025-06-30

Family

ID=96230120

Family Applications (1)

Application Number Title Priority Date Filing Date
MA63526A MA63526A1 (en) 2023-12-19 2023-12-19 Composition based on hemp seeds for therapeutic use

Country Status (1)

Country Link
MA (1) MA63526A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021072045A1 (en) * 2019-10-08 2021-04-15 Jenny's Rose, LLC Therapeutic cannabis extracts
US20220226406A1 (en) * 2021-01-18 2022-07-21 Famenity Co., Ltd. Composition containing extract of cannabis sativa for preventing or treating metabolic syndrome-related disease
WO2023064478A1 (en) * 2021-10-13 2023-04-20 Portland Technology Holdings Llc Hemp extract for treatment of pain, cancer and epilepsy in animals
EP4181940A1 (en) * 2020-07-15 2023-05-24 Linnea S.A. Cannabis sativa extracts and their uses

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021072045A1 (en) * 2019-10-08 2021-04-15 Jenny's Rose, LLC Therapeutic cannabis extracts
EP4181940A1 (en) * 2020-07-15 2023-05-24 Linnea S.A. Cannabis sativa extracts and their uses
US20220226406A1 (en) * 2021-01-18 2022-07-21 Famenity Co., Ltd. Composition containing extract of cannabis sativa for preventing or treating metabolic syndrome-related disease
WO2023064478A1 (en) * 2021-10-13 2023-04-20 Portland Technology Holdings Llc Hemp extract for treatment of pain, cancer and epilepsy in animals

Similar Documents

Publication Publication Date Title
PL364458A1 (en) N-(2-arylethyl)benzylamines as antagonists of the 5-ht6
CY1122370T1 (en) COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS
JP1747428S (en) shoes
CL2020003341S1 (en) Interface of a battery. (divisional request 201903647)
NO20073801L (en) Atineoplastic combinations
DK1521573T3 (en) Non-polymeric, lipophilic, pharmaceutical implant compositions for intracellular use
UY28290A1 (en) NEW PHARMACEUTICAL COMPOUNDS
CY1117639T1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON THE CRYSTAL FORM OF I-5-AZAKYTIDINE
EA200401526A1 (en) NEW CONNECTIONS AND THEIR APPLICATION
MA30798B1 (en) THIAZOLE PYRAZOLOPYRIMIDINES AS CRF1 RECEPTOR ANTIGONISTS
TNSN06187A1 (en) SUBSTITUTED ARYLPYRAZOLES AS PARASITICIDES
CY1105877T1 (en) OPHTHALMIC COMPOSITIONS THREE-POLYME ADHESIVE COMPOSITIONS
CA3257736A1 (en) Compound for inhibiting or degrading bcl6 and use thereof in pharmaceutics
TN2011000551A1 (en) ANTITUMOR COMBINATION COMPRISING AVE8062 AND SORAFENIB
ECSP045027A (en) MUSCARINIC AGONISTS
EP4037687A4 (en) BENZOXAZINONE COMPOUNDS USED AS DUAL KLK5/7 INHIBITORS
MA63526A1 (en) Composition based on hemp seeds for therapeutic use
NO20063393L (en) Pharmaceutical preparations
TW200619848A (en) Photoresist compositions
DE602005022346D1 (en) RADIOACTIVELY MARKED LIGANDS ON CHINOLINE BASE FOR 5-HT6 RECEPTOR FUNCTIONALITY
NO20063293L (en) Pharmaceutical compounds
CR20230266A (en) NEW FORMULATION FOR ORAL ADMINISTRATION, WHICH COMPRISES 1-(5-(2,4-DIFLUOROPHENYL)-1-((3-FLUOROPHENYL)SULFONYL)-4-METHOXY-1H-PYRROL-3-IL)-N-METHYLMETHANAMINE
FR3140767B3 (en) SUPPORT FOR SIGNAL PLATES
UA47864S (en) 1. SOLE
UA47863S (en) 1. SOLE